About: AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.13 (-5.94%)
AEON NYSE AEON Biopharma, Inc.
AEON Biopharma, Inc. share price
AEON price activity
Last Price
$0.130
Change (24hr)
-0.01 USD (5.94%)
Volume
1.02M
Volume (4w avg)
-
Open
$0.13
Day Range
$0.12 - $0.13
Previous Close
$0.13
Last Trade
20 Nov, 9:00 pm GMT+0
Delayed
20 Nov, 9:00 pm GMT+0
AEON price performance
Delayed
20 Nov, 9:00 pm GMT+0
AEON details
AEON Market Signals